Beyond APHINITY: What Now After Pivotal Breast Cancer Trial?

Dr Kathy Miller speaks with APHINITY ' s principal investigator about whether survival in HER2+ disease can be pushed even further.

Source: Medscape Oncology - February 15, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts